Delving into the Latest Updates on AceEMzyme Co. Ltd. with Synapse

概览

疾病领域	数量

神经系统疾病	1
肿瘤	1

排名前五的药物类型	数量

酶	4

关联

4

项与 AceEMzyme Co. Ltd. 相关的药物

Ace-HK20

靶点-

作用机制-

在研机构

AceEMzyme Co. Ltd.

原研机构

AceEMzyme Co. Ltd.

在研适应症

肿瘤

非在研适应症-

最高研发阶段临床前

首次获批国家/地区-

首次获批日期-

KGR3M

靶点-

作用机制-

在研机构

AceEMzyme Co. Ltd.

原研机构

AceEMzyme Co. Ltd.

在研适应症

胃病

非在研适应症-

最高研发阶段临床前

首次获批国家/地区-

首次获批日期-

RH2M

靶点-

作用机制-

在研机构

AceEMzyme Co. Ltd.

原研机构

AceEMzyme Co. Ltd.

在研适应症

记忆障碍

非在研适应症-

最高研发阶段临床前

首次获批国家/地区-

首次获批日期-

100 项与 AceEMzyme Co. Ltd. 相关的临床结果

登录后查看更多信息

0 项与 AceEMzyme Co. Ltd. 相关的专利（医药）

登录后查看更多信息

46

项与 AceEMzyme Co. Ltd. 相关的文献（医药）

2024-04-24·International Journal of Systematic and Evolutionary Microbiology

Corrigendum: Solibacillus palustris sp. nov., isolated from wetland soil of ecology park

Article

作者: Im, Wan-Taek ; Lee, Kang-Hyun ; Lee, Soon-Youl Lee ; Rhee, Moon-Soo ; Jo, Jung-Hun ; Chun, Se-Yoon

2024-02-07·International Journal of Systematic and Evolutionary Microbiology

Solibacillus palustris sp. nov., isolated from wetland soil of ecology park

Article

作者: Im, Wan-Taek ; Lee, Kang-Hyun ; Rhee, Moon-Soo ; Jo, Jung-Hun ; Lee, Soon-Youl ; Chun, Se-Yoon

A Gram-staining-positive, motile, aerobic and rod-shaped bacterium, designated strain MA9T was isolated from wetland soil of ecology park, in Seoul, Republic of Korea. This bacterium was characterized to determine its taxonomic position by using the polyphasic approach. Strain MA9T grew at 10–37 °C and at pH 6.0–9.5 on TSB. Menaquinone MK-7 was the predominant respiratory quinone and iso-C15 : 0, iso-C16 : 0 and C16 : 1 ω7c alcohol were the major fatty acids. The main polar lipids were phosphatidylethanolamine (PE), phosphatidylserine (PS), diphosphatidylglycerol (DPG) and phosphatidylglycerol (PG). The peptidoglycan type of the cell wall was A4α l-Lys-d-Glu. Based on 16S rRNA gene sequencing, strain MA9T clustered with species of the genus Solibacillus and appeared closely related to S. silvestris DSM 12223T (97.8 % sequence similarity), S. cecembensis DSM 21993T (97.6 %), S. isronensis DSM 21046T (97.6 %) and S. kalamii DSM 101595T (96.6 %). The G+C content of the genomic DNA was 37.0 mol%. Digital DNA–DNA hybridization between strain MA9T and type strains of S. silvestris, S. isronensis, S. cecembensis and S. kalamii resulted in values below 70 %. Strain MA9T could be differentiated genotypically and phenotypically from the recognized species of the genus Solibacillus. The isolate therefore represents a novel species, for which the name Solibacillus palustris sp. nov. is proposed, with the type strain MA9T (=KACC 22212T = LMG 32188T)

2023-12-01·Journal of Genetic Engineering and Biotechnology

Repressing effect of transformed ginsenoside Rg3-mix against LPS-induced inflammation in RAW264.7 macrophage cells

Article

作者: Hwang, Seong-Gu ; Marium, Zuneera ; Im, Wan-Taek ; Siddiqi, Muhammad Zubair ; Lee, Ji-Hye

AbstractBackgroundRg3-ginsenoside, a protopanaxadiol saponin, is a well-known adaptogen used for the prevention of cancer and inflammation. However, despite its distinct biological activity, the concentration of Rg3 in the total ginseng extract is insufficient for therapeutic applications. This study aims to convert PPD-class of major ginsenosides into a mixture of minor ginsenoside, to analyze its immune-regulatory role in macrophage cells.ResultsUsing heat and organic acid treatment, three major ginsenosides, Rc, Rd, and Rb1, were converted into a mixture of minor ginsenosides, GRg3-mix [Rg3(S), Rg3(R), Rg5, and Rk1]. Purity and content analysis of the transformed compound were performed using thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC), compared with their standards. Preceding with the anti-inflammatory activity of GRg3-mix, lipopolysaccharide (LPS)-stimulated murine RAW264.7 macrophage cells were treated with various concentrations of GRg3-mix (6.25, 12.5, 25, and 50 μg/mL). The cell viability assay revealed that the level of cell proliferation was increased, while the nitric oxide (NO) assay showed that NO production decreased dose-dependently in activated RAW264.7 cells. The obtained results were compared to those of pure Rg3(S) ≥ 98% (6.25, 12.5, and 25 μg/mL). Preliminary analysis of the CCK-8 and NO assay demonstrated that GRg3-mix can be used as an anti-inflammatory mediator, but mRNA and protein expression levels were evaluated for further confirmation. The doses of GRg3-mix significantly suppressed the initially upregulated mRNA and protein expression of inflammation-related enzymes and cytokines, namely inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), nuclear transcription factor kappa B (NF-κB), tumor necrosis factor (TNF-α), and interleukins (IL-6 and IL1B), as measured by reverse transcription-polymerase chain reaction and western blotting.ConclusionsOur pilot data confirmed that the mixture of minor ginsenosides, namely GRg3-mix, has high anti-inflammatory activity and has an easy production procedure.

100 项与 AceEMzyme Co. Ltd. 相关的药物交易

登录后查看更多信息

100 项与 AceEMzyme Co. Ltd. 相关的转化医学

登录后查看更多信息